US Cold Plasma Market (2024-2029)
The US Cold Plasma Market was valued at $310.31 Million in 2024 and projected to reach to $509.51 Million by 2029, representing a compound annual growth rate of CAGR 10.4%. The US cold plasma market is positioned for sustained expansion through 2029, with the projected market size reaching $509.51 million representing a 64% increase from 2024 levels.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Cold Plasma Market Trends and Insights
- The US healthcare sector is increasingly adopting cold plasma technology for wound healing, sterilization, and dermatological applications, driven by rising demand for minimally invasive treatment options.
- The US market's 10.4% compound annual growth rate reflects strong clinical adoption and regulatory support within the country's advanced healthcare infrastructure. In the US, cold plasma adoption is accelerating across hospitals, surgical centers, and specialty clinics as healthcare providers recognize its efficacy in infection control and tissue regeneration.
- The US regulatory environment, supported by FDA oversight and clinical validation, has bolstered confidence in cold plasma devices among US healthcare practitioners.
- Between 2024 and 2029, the US market is expected to capture significant share growth as US manufacturers expand production capacity and US healthcare systems integrate cold plasma into standard treatment protocols..
Key Market Statistics
- CAGR (2024-2029) CAGR 10.4%
- Market Size, 2024 ~USD 310.31 Million
- Forecast, 2029 ~USD 509.51 Million
- Country US
US Cold Plasma Market Overview
Market Valuation :
The US cold plasma market reached $310.31 million in 2024, demonstrating strong market penetration across healthcare facilities and clinical settings nationwide.
Robust Growth Trajectory :
With a 10.4% CAGR through 2029, the US market is expanding faster than many competing medical technologies, reflecting accelerating adoption rates among US healthcare providers.
Clinical Application Expansion :
US hospitals and clinics are increasingly deploying cold plasma for wound healing, surgical sterilization, and dermatological treatments, driven by proven efficacy and minimally invasive benefits.
Minimally Invasive Preference :
Rising US patient demand for non-invasive treatment options and reduced recovery times is propelling cold plasma adoption across major healthcare systems and outpatient facilities.
US Cold Plasma Market Dynamics
- This growth is underpinned by increasing FDA approvals, expanding clinical evidence supporting efficacy, and growing integration into US hospital protocols.
- Healthcare providers are recognizing cold plasma's versatility across multiple therapeutic areas, from chronic wound management to surgical site sterilization. Key drivers include the US healthcare system's shift toward value-based care, patient preference for minimally invasive procedures, and rising healthcare expenditures supporting advanced technology adoption.
- Regulatory support and reimbursement improvements are expected to accelerate market penetration, particularly in outpatient and specialty care settings across major US metropolitan areas..
Market Ecosystem
COLD PLASMA MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Enables controlled plasma processing for high-precision manufacturing, improving process uniformity and supporting advanced semiconductor and electronics production. | Develops plasma generators and plasma processing technologies used in semiconductor, electronics, and thin-film manufacturing applications, including etching, deposition, and surface treatment under controlled plasma conditions. |
 |
Enables precise, automated plasma treatment for surface modification, cleaning, and adhesion improvement, supporting consistent processing and reduced use of chemical pretreatment. | Provides plasma-based surface treatment solutions used for cleaning, activation, and surface modification of plastics, metals, glass, and electronic components | These systems help improve coating and adhesive bonding while supporting automated manufacturing processes. |
 |
Improves surface energy, adhesion, and wettability while enabling inline, chemical-free surface treatment with high process consistency. | Develops atmospheric-pressure plasma systems, including Openair-Plasma, for surface cleaning, activation, functionalization, and coating preparation across automotive, electronics, medical, and polymer industries. |
 |
Develops high-performance cleanroom garments, protective materials, and barrier fabrics used in pharmaceutical, semiconductor, and microelectronics facilities. | Provides atmospheric-pressure plasma systems for surface activation, cleaning, and functionalization of plastics, composites, metals, and other materials | Its plasma solutions can be integrated into automated production lines for continuous treatment. |
 |
Provides access to specialized plasma and scientific instrumentation technologies supporting advanced research, surface treatment, and industrial processing applications. | Through its scientific-instrumentation subsidiaries, supports specialized technologies used in research, materials analysis, plasma processing, and advanced industrial applications, depending on the subsidiary and product portfolio. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The US cold plasma market is valued at $310.31 million in 2024 and will reach $509.51 million by 2029, representing a 10.4% CAGR.
- US healthcare providers are rapidly adopting cold plasma for wound care, sterilization, and dermatological treatments due to minimally invasive benefits.
- The US regulatory framework and FDA approval pathways are accelerating clinical adoption and market expansion across US medical institutions.
- US manufacturers are scaling production to meet growing demand, positioning the country as a key hub for cold plasma technology development and deployment.
Cold Plasma Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MEDICAL INDUSTRY (Industry) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11% from 2024 to 2029 |
| Largest Segment | ATMOSPHERIC COLD PLASMA (Regime) |
| Market Size Base Year (Billions) | ~USD 2.14 (2024) |
| Revenue Forecast (Billions) | ~USD 3.6 (2029) |
| Segments Covered | Industry, Application, Regime |
US Cold Plasma Market Report Segmentation
3 segment dimensions are covered across the global market.
By Industry
- Cosmetic Industry
- Electronics & Semiconductors Industry
- Food & Agriculture Industry
- Medical Industry
- Other Industries
- Polymer & Plastic Industry
- Textile Industry
By Application
- Aesthetic Procedures
- Coating & Thin-Film Deposition
- Other Applications
- Printing
- Surface Cleaning & Decontamination
- Surface Etching
- Surface Treatment & Activation
- Surgical
- Wound Healing
By Regime
- Atmospheric Cold Plasma
- Low-Pressure Cold Plasma
US: COLD PLASMA MARKET, BY INDUSTRY, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| COSMETIC INDUSTRY | 22.4 | 23.3 | 24.8 | 26.8 | 28.8 | 31.4 | 34.6 | 38.2 | 9.1 |
| ELECTRONICS & SEMICONDUCTORS INDUSTRY | 135 | 142.9 | 154.7 | 170.3 | 187 | 207.5 | 232.3 | 261.3 | 11.1 |
| FOOD & AGRICULTURE INDUSTRY | 53.1 | 55.7 | 59.7 | 65.1 | 70.8 | 77.8 | 86.3 | 96.2 | 10 |
| MEDICAL INDUSTRY | 61.1 | 66.1 | 73.2 | 82.3 | 92.4 | 104.8 | 120 | 138 | 13.5 |
| OTHER INDUSTRIES | 9.9 | 10.2 | 10.7 | 11.5 | 12.2 | 13.1 | 14.3 | 15.6 | 10 |
| POLYMER & PLASTIC INDUSTRY | 273.9 | 288.3 | 310.3 | 339.6 | 370.8 | 409.1 | 455.5 | 509.5 | 10.4 |
| TEXTILE INDUSTRY | 184.9 | 193.2 | 206.4 | 224.1 | 242.9 | 265.9 | 293.8 | 326.2 | 9.6 |
| TOTAL | 740.3 | 779.8 | 839.8 | 919.7 | 1005 | 1109.7 | 1236.8 | 1385 | 10.5 |
Target Audience
- Medical Device Manufacturers : Evaluate US market opportunity for cold plasma device development and commercialization, with specific sizing data to support R&D investment and launch planning decisions.
- Healthcare System Executives : Assess cold plasma technology adoption potential within your US hospital network, understanding market trends and clinical ROI to guide capital equipment procurement strategies.
- Investment & Private Equity Firms : Identify high-growth US cold plasma companies and market segments for acquisition or funding, backed by validated market sizing and 5-year growth projections.
- Healthcare Consultants & Advisors : Support client strategy development with authoritative US cold plasma market data, competitive positioning analysis, and clinical adoption forecasts for advisory engagements.
- Regulatory & Compliance Officers : Monitor US market dynamics, reimbursement trends, and regulatory developments affecting cold plasma commercialization and market access strategies.
Reasons to Buy this Report
- Market Size & Growth Validation : Confirm the US cold plasma market's $310.31M valuation and 10.4% CAGR trajectory through 2029, providing data-driven confidence for investment and expansion decisions.
- US-Specific Clinical Insights : Access detailed analysis of cold plasma adoption patterns across US wound care, surgical sterilization, and dermatology segments to identify high-opportunity clinical verticals.
- Competitive Positioning Strategy : Benchmark your US market position against competitors with country-specific data on adoption rates, reimbursement trends, and healthcare provider preferences.
- Regulatory & Reimbursement Landscape : Understand US FDA approval pathways, insurance coverage evolution, and reimbursement dynamics shaping market accessibility and revenue potential through 2029.
- Strategic Market Entry Planning : Leverage US-focused forecasts and regional healthcare system insights to develop targeted go-to-market strategies and identify priority geographic markets for expansion.
Frequently asked questions
What is the current size of the US cold plasma market?
The US cold plasma market was valued at $310.31 million in 2024 and is expected to grow to $509.51 million by 2029.
What is the growth rate of the US cold plasma market?
The US cold plasma market is growing at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2029.
What are the primary applications of cold plasma in the US healthcare market?
In the US, cold plasma is primarily used for wound healing, surgical sterilization, infection control, and dermatological treatments across hospitals and specialty clinics.
What factors are driving growth in the US cold plasma market?
US market growth is driven by increasing adoption of minimally invasive treatments, FDA regulatory support, clinical validation, and expanding healthcare provider awareness of cold plasma efficacy.
Which US healthcare settings are adopting cold plasma technology?
US hospitals, surgical centers, specialty clinics, and wound care facilities are actively integrating cold plasma devices into their treatment protocols and standard care pathways.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the size of the cold plasma market. Exhaustive secondary research was conducted to gather information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the cold plasma technologies market. It was also used to obtain important information about key players, market classification and segmentation according to industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the cold plasma market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
The research methodology used to estimate the size of the cold plasma market is as follows.
Market sizing was conducted from a global perspective.
Country-level Analysis: The size of the cold plasma market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall cold plasma market was obtained from secondary data and validated by primary participants to arrive at the total cold plasma market. Primary participants further validated the numbers.
Geographic Market Assessment (Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall cold plasma technologies market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Data Triangulation
After determining the overall size of the global cold plasma market using the aforementioned methodology, the market was segmented into several subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and ground- and excited-state molecules. It is an innovative and convenient alternative to traditional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.
Key Stakeholders
- Cold plasma manufacturers and distributors
- Government and research organizations
- Cold plasma application industries
- Plasma technology component suppliers
- Medical device manufacturing companies
- Healthcare organizations
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
- Corporate entities
Report Objectives
- To describe, analyze, and forecast the cold plasma market by industry, application, regime, and region
- To describe and forecast the cold plasma market in key regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing market growth
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the cold plasma market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the cold plasma market
- To analyze the impact of AI/Gen AI on the cold plasma market in terms of its capabilities, potential, use cases, and future
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific cold plasma market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Europe cold plasma market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Latin America cold plasma market into Argentina, Peru, and other countries
- Further breakdown of Rest of Middle East & Africa cold plasma market into Israel, Iran, Iraq, Jordan, Yemen, and other countries.
Get the Full Cold Plasma Market Report
Full forecast, segment splits, and company analysis for all Cold Plasma Market.
- Canada Cold Plasma Market
- Germany Cold Plasma Market
- France Cold Plasma Market
- UK Cold Plasma Market
- Italy Cold Plasma Market
- Spain Cold Plasma Market
- China Cold Plasma Market
- Japan Cold Plasma Market
- India Cold Plasma Market
- South Korea Cold Plasma Market
- Australia Cold Plasma Market
- Brazil Cold Plasma Market
- Mexico Cold Plasma Market
- Rest Of Europe Cold Plasma Market
- Rest Of Asia Pacific Cold Plasma Market
- Rest Of Latin America Cold Plasma Market
- GCC Countries Cold Plasma Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
